Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saf-T-Med was a medical technology company focused on the design and manufacture of safety-engineered injection systems. The company developed proprietary retractable needle technology and safety syringes aimed at reducing the risk of accidental needlestick injuries among healthcare professionals. Its products were designed to meet the requirements of the Needlestick Safety and Prevention Act in the United States. In 2001, Saf-T-Med was acquired by Becton Dickinson (BD), which integrated the technology into its industry-leading portfolio of safety-engineered medical devices. The acquisition allowed BD to expand its intellectual property and product offerings in the rapidly growing safety device market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saf-T-Med.